(VIANEWS) – Cronos Group (NASDAQ: CRON) shares have experienced an astounding surge of 32.49% since November 18, 2013, rising from EUR1.97 to EUR2.61. This rise came after experiencing a drop in performance the prior session; yet even with overall market decline of 0.12% reaching EUR16,379.46 this day; Cronos Group was still able to outshone market performance, closing at 1.14% below their 52-week high of EUR2.64.
About Cronos Group
Cronos Group Inc. is a pioneering cannabinoid company focused on cultivating, producing, and marketing high-quality cannabis products across Canada, Israel and Germany. Boasting brands such as Spinach, Lord Jones and PEACE NATURALS among many others; Cronos offers products such as dried flower, pre-rolls, oils, vaporizers edibles and cannabis tinctures. Established in 2012 and headquartered out of Toronto Canada – Cronos is committed to offering innovative yet sustainable solutions in an increasingly booming global cannabis market
Yearly Analysis
Cronos Group’s stock is currently trading at EUR2.61, below its 52-week high of EUR2.64. This indicates that its performance over the past year has been mixed; however, its performance over its most recent low of EUR1.64 shows signs of strength relative to recent past results.
Anticipated Sales Growth:
According to information provided, Cronos Group anticipates experiencing sales growth of 15.1% this year and 14.1% next year – suggesting a positive trajectory that may eventually result in higher stock prices.
Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA):
Cronos Group has reported an EBITDA of -1.17 for 2018 which indicates it is currently operating at a loss. While this might cause concern among investors as negative EBITDA can indicate financial instability; investors should keep in mind that EBITDA should only be taken as one metric when assessing company finances alongside revenue, cash flow and profit margin metrics.
Overall, according to the information available, Cronos Group appears to be trading below its 52-week high but above its 52-week low. Expected sales growth is positive while EBITDA has decreased; investors should take these factors and other key metrics and market trends into consideration when making investment decisions; it may be worthwhile seeking professional advice for more personalized advice.
Technical Analysis
Cronos Group Stock Price Exceeds Moving AveragesCronos Group’s stock price has been on an upward trajectory, trading above both its 50-day moving average of EUR2.09 and 200-day moving average of EUR1.96, signalling potential investor success. The rise shows the stock is experiencing strong upward momentum – something investors should welcome as a promising sign.
Increased Trading VolumeFor Cronos Group, trading volume has also been on an upswing, with today’s reported volume being 93.10% higher than its average volume of 2572200. This indicates a rising interest in its stock, potentially fueling further price appreciation.
Cronos Group’s intraday volatility has been relatively moderate, with its current variation average over the past week, month, and quarter being 1.16%, 1.27%, and 2.66%, respectively. Cronos Group stock experienced its highest amplitude of average volatility within any one period being 4.37% (week), 2.77% (month), and 2.66% (quarter).
Cronos Group Stock Is Considered OversoldAccording to its stochastic oscillator, Cronos Group stock may currently be oversold (=20), suggesting a potential turnaround in its price trend and offering investors the chance to acquire it at relatively lower prices and potentially benefit from further price rises in future years.
Overall, Cronos Group’s stock seems to be performing strongly with strong upward momentum and increasing trading volume. Although its volatility has been relatively moderate, its oversold status according to stochastic oscillator may indicate a possible change in trend; investors should carefully consider these indicators prior to making investment decisions.
Quarter Analysis
Earnings OutlookDimensiuni For 2018, Cronos Group anticipates their earnings per share (EPS) will experience 50% year-on-year growth to reach 0.09 EPS for next year, due to strong sales and revenue increases. This growth can be seen through strong sales increases as well as revenue expansion. However, it should be noted that Cronos Group’s earnings are currently not profitable; with an accumulated negative net income of -117.84M for the twelve trailing months ending April 2018.ValuationCronos Group currently boasts a market capitalization of 8.3B and has a price-earnings (P/E) ratio of 119.83. Cronos Group’s high price/earnings ratio indicates that investors expect strong future growth from Cronos Group; however, its stock may be overvalued relative to its earnings. Investors should carefully assess the valuation of stock against its earnings potential and risks. One major risk facing Cronos Group is regulatory risk. As a cannabis industry operator, Cronos Group must comply with stringent legal regulations both domestically and abroad. Any changes could have serious ramifications for both its operations and financial performance. Cronos Group faces competition from other players in the industry, including larger firms with well-established brands and wider distribution networks. ConclusionCronos Group’s strong sales and revenue growth as well as projected earnings growth could make its stock an appealing investment opportunity for cannabis industry investors; however, prospective investors must carefully evaluate all risks related to operation valuation before making their own informed investment decision.
Equity Analysis
Earnings Per Share Outlook Cronos Group’s trailing twelve month earnings per share figure of EUR-0.18 is significantly negative and not indicative of future performance; investors should monitor earnings reports to ascertain if there has been any improvement. Negative earnings per share can often serve as a warning sign to investors. Return on Equity OutlookThe company’s negative return on equity of -6.3% over its twelve trailing months should cause concern to shareholders. Negative Return of Equity suggests that a company is failing to generate profits for its shareholders. However, it should be kept in mind that a company’s Return of Equity can fluctuate over time and investors should closely follow its financial statements to detect any positive shifts.Investment OutlookBased on this data, Cronos Group’s negative EPS and ROE figures should cause concern to investors. Investors should carefully assess these financial metrics alongside other relevant considerations such as company management, market trends and industry conditions before making investment decisions. As an additional resource, consulting with a financial advisor may also help gain a clearer understanding of Cronos Group’s finances and potential for growth. Unfortunately, its negative EPS and ROE figures suggest the company is currently not producing profits for shareholders. Although past performance may not provide a clear indication of future outcomes, investors should monitor a company’s financial statements and other key metrics closely for any positive changes that may indicate future success. It may also be beneficial to speak to an advisor regarding its health and potential growth opportunities.
More news about Cronos Group (CRON).
